The most popular stories and special reports in FierceBiotech Research, FiercePharmaManufacturing, and the rest of our Life Sciences publications

We hope you've found this year's roundup of the most popular content on the web interesting. Below, you'll find the top-visited stories and special reports from each of our weekly and semi-weekly publications this year. The content is listed by popularity in descending order.

We'll be back on Monday with our regular coverage. Enjoy the leftovers.

Suggested Articles

A TGen-led research team found that increased activity of the gene AEBP1 drives severe liver fibrosis in nonalcoholic steatohepatitis.

Days after announcing its R&D chief was stepping down, Gilead announced it will be buying a few of Novartis’ unwanted early-stage infection assets.

Mallinckrodt is teaming up with Silence Therapeutics to develop an RNAi program aimed at a group of proteins that play a part in promoting inflammation.